Today, and welcome to the GlucoTrack Inc special meeting of stockholders. I would now like to turn the conference over to Dr. Paul Goode. Please go ahead.
Thank you. Welcome to the reconvened virtual special meeting of stockholders of GlucoTrack Inc. This meeting was originally called to order on October 31st, 2025, but was adjourned due to the absence of a quorum. It is now 12:00 P.M. Eastern Time on November 7th, 2025, and the meeting will please come to order. My name is Paul Goode, and as Chief Executive Officer, I will preside over this meeting. Also present are Peter Wolfe, our Chief Financial Officer, and Kathryn Simons from Nelson Mullins Riley & Scarborough LLP, the company's outside counsel, who will act, excuse me, as Inspector of Elections for this meeting. We have adopted an agenda for our program this morning. In accordance with the agenda, we will proceed as follows. I will conduct the official business of the special meeting.
During this portion of the meeting, all discussion will be limited to the official business at hand, and participation will be limited to stockholders of record and their proxies. If you wish to participate in this meeting, please follow the instructions on your screen. The matters on which the stockholders present or represented at the meeting are voting on are as follows: a proposal to approve, for purposes of complying with NASDAQ Listing Rule 5635(d), the full issuance of shares of common stock of the company to Sixborough Capital Fund LP pursuant to that certain purchase agreement dated September 11, 2025, by and between the company and Sixborough, which shares may represent more than 20% of the company's issued and outstanding common stock as of the date of the purchase agreement, which we refer to as the issuance proposal.
We will now proceed to the business portion of this meeting. We have an affidavit from Broadridge Financial Solutions certifying that on or about October 3rd, 2025, each stockholder of record was mailed an official notice of this meeting together with a proxy statement, proxy card, and any other material necessary to vote at this meeting. The list of the stockholders entitled to vote at this meeting has been available at company headquarters for the past 10 days for the inspection of any stockholder entitled to vote. The company has appointed Kathryn Simons to serve as Inspector of Elections on behalf of the company for this meeting, and she will tabulate the results of the voting. Her oath as Inspector has been submitted and will also be appended to the minutes of this meeting. Mr. Wolfe, do you have a report regarding the existence of a quorum?
Thank you, Dr. Goode. Yes, indeed. Broadridge Financial Solutions has examined the proxies received and reports that shares entitled to 158,370 votes were approximately 17.6% of the total votes of holders of shares of our common stock entitled to be cast at this meeting. Are present and are represented by the proxy held by myself. The preliminary results indicate that we do not have a quorum for the purpose of transacting business at this meeting.
Thank you, Mr. Wolfe. As we still do not have a quorum present and after diligent efforts to solicit additional proxies, it has been determined that the special meeting of stockholders of GlucoTrack Inc will be permanently adjourned. No further business will be conducted, and the meeting is now officially closed. On behalf of the Board of Directors and Management, I would like to thank all stockholders and participants for their time and efforts. The meeting is now permanently adjourned.
The conference has now concluded. Thank you for attending. You may now disconnect.